2025/2534(DEA)
OTC derivatives identifying reference data to be used for the purposes of the transparency requirements laid down in Article 8a(2) and Articles 10 and 21
Basic information
2025/2534(DEA)
DEA - Delegated acts procedure
Supplementing 2011/0296(COD)
Subject
2.50.03 Securities and financial markets, stock exchange, CIUTS, investments
2.50.08 Financial services, financial reporting and auditing
2.50.10 Financial supervision
Status
Awaiting committee decision
Key players
-
European Parliament
Committee responsible Rapporteur Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 24/01/2025 | Non-legislative basic document published | C(2025)00417 | |
| 24/01/2025 | Initial period for examining delegated act 3.0 month(s) | ||
| 12/02/2025 | Committee referral announced in Parliament |
Technical information
| Procedure reference | 2025/2534(DEA) |
|---|---|
| Procedure type | DEA - Delegated acts procedure |
| Procedure subtype | Examination of delegated act |
| Supplementing 2011/0296(COD) | |
| Stage reached in procedure | Awaiting committee decision |
| Committee dossier |
ECON/10/01997
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2025)00417 24/01/2025